Tributylmethylammonium

Tributylmethylammonium

SCHEMBL241993

CCCC[N+](C)(CCCC)CCCC.COP(=O)([O-])OC

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.44
AKT1 P31749 2/20 0.44
ESR1 P03372 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CDC25A P30304 1/20 0.44
AGTR1 P30556 1/20 0.44
ADRA1A P35348 1/20 0.44
KCNH2 Q12809 1/20 0.44
PRKD3 O94806 1/20 0.38
PRKCG P05129 1/20 0.38
PRKCB P05771 1/20 0.38
PRKCA P17252 1/20 0.38
PRKCH P24723 1/20 0.38
PRKCI P41743 1/20 0.38
PRKCE Q02156 1/20 0.38
PRKCQ Q04759 1/20 0.38
PRKCZ Q05513 1/20 0.38
PRKCD Q05655 1/20 0.38
PRKD1 Q15139 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625997 0.94 LMNA (0.47) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL626714 0.92 LMNA (0.50) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL18145299 0.92 LMNA (0.50) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL626402 0.87 LMNA (0.39) LMNAAKT1ESR1ADORA3CDC25A
Tributylmethylammonium SCHEMBL12816054 0.87 LMNA (0.44) LMNAAKT1ESR1ADORA3CDC25A
Tetrabuthylammonium SCHEMBL21407823 0.85 SLC22A1 (0.52) LMNAAKT1ESR1ADORA3CDC25A
Tributylmethylammonium SCHEMBL14777172 0.82 BBOX1 (0.45) LMNAAKT1ESR1ADORA3CDC25A
Tributylmethylammonium SCHEMBL3267256 0.82 LMNA (0.51) LMNAAKT1ESR1ADORA3CDC25A
Phosphoric Acid SCHEMBL29166640 0.80 DNM1 (0.54) LMNAAKT1ESR1ADORA3CDC25A
Tributylmethylammonium SCHEMBL1969906 0.80 LMNA (0.40) LMNAAKT1ESR1ADORA3CDC25A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8871924-B2 Regioselectively substituted cellulose esters produced in a tetraalkylammonium alkylphosphate ionic liquid process and products produced therefrom EASTMAN CHEMICAL COMPANY (US) 2014-10-28 US claimed
US-8524887-B2 Regioselectively substituted cellulose esters produced in a tetraalkylammonium alkylphosphate ionic liquid process and products produced therefrom EASTMAN CHEMICAL COMPANY (US) 2013-09-03 US claimed
US-20120121830-A1 REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS PRODUCED IN A TETRAALKYLAMMONIUM ALKYLPHOSPHATE IONIC LIQUID PROCESS AND PRODUCTS PRODUCED THEREFROM EASTMAN CHEMICAL COMPANY (US) 2012-05-17 US claimed
EP-2419454-A1 CELLULOSE SOLUTIONS COMPRISING TETRAALKYLAMMONIUM ALKYLPHOSPHATE AND PRODUCTS PRODUCED THEREFROM Eastman Chemical Company (US) 2012-02-22 EP claimed
US-20120041080-A1 CELLULOSE SOLUTIONS COMPRISING TETRAALKYLAMMONIUM ALKYLPHOSPHATE AND PRODUCTS PRODUCED THEREFROM EASTMAN CHEMICAL COMPANY (US) 2012-02-16 US claimed
US-8067488-B2 Cellulose solutions comprising tetraalkylammonium alkylphosphate and products produced therefrom EASTMAN CHEMICAL COMPANY (US) 2011-11-29 US claimed
US-20100305249-A1 CELLULOSE SOLUTIONS COMPRISING TETRAALKYLAMMONIUM ALKYLPHOSPHATE AND PRODUCTS PRODUCED THEREFROM EASTMAN CHEMICAL COMPANY (US) 2010-12-02 US claimed
WO-2010120269-A1 CELLULOSE SOLUTIONS COMPRISING TETRAALKYLAMMONIUM ALKYLPHOSPHATE AND PRODUCTS PRODUCED THEREFROM EASTMAN CHEMICAL COMPANY (US) 2010-10-21 WO claimed
EP-3601372-B1 REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS EASTMAN CHEM CO (US) 2024-11-06 EP disclosed
US-20240352224-A1 REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTER BASED NEGATIVE BIREFRINGENT COMPENSATION FILMS HAVING IMPROVED WAVELENGTH DISPERSION EASTMAN CHEMICAL COMPANY (US) 2024-10-24 US disclosed
EP-3601369-B1 REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS EASTMAN CHEM CO (US) 2024-09-18 EP disclosed
EP-4384571-A1 REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTER BASED NEGATIVE BIREFRINGENT COMPENSATION FILMS HAVING IMPROVED WAVELENGTH DISPERSION Eastman Chemical Company (US) 2024-06-19 EP disclosed
US-12006375-B2 Regioselectively substituted cellulose esters EASTMAN CHEMICAL COMPANY (US) 2024-06-11 US disclosed
EP-3601371-B1 REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS EASTMAN CHEM CO (US) 2024-04-10 EP disclosed
US-20120003403-A1 MULTILAYER CELLULOSE ESTER FILM HAVING REVERSED OPTICAL DISPERSION EASTMAN CHEMICAL COMPANY (US) 2012-01-05 US disclosed
US-8067488-B2 Cellulose solutions comprising tetraalkylammonium alkylphosphate and products produced therefrom EASTMAN CHEMICAL COMPANY (US) 2011-11-29 US disclosed
US-20100305249-A1 CELLULOSE SOLUTIONS COMPRISING TETRAALKYLAMMONIUM ALKYLPHOSPHATE AND PRODUCTS PRODUCED THEREFROM EASTMAN CHEMICAL COMPANY (US) 2010-12-02 US disclosed
WO-2010120269-A1 CELLULOSE SOLUTIONS COMPRISING TETRAALKYLAMMONIUM ALKYLPHOSPHATE AND PRODUCTS PRODUCED THEREFROM EASTMAN CHEMICAL COMPANY (US) 2010-10-21 WO disclosed
WO-2010120268-A1 REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS PRODUCED IN A TETRAALKYLAMMONIUM ALKYLPHOSPHATE IONIC LIQUID PROCESS AND PRODUCTS PRODUCED THEREFROM EASTMAN CHEMICAL COMPANY (US) 2010-10-21 WO disclosed
US-20100267942-A1 REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS PRODUCED IN A TETRAALKYLAMMONIUM ALKYLPHOSPHATE IONIC LIQUID PROCESS AND PRODUCTS PRODUCED THEREFROM EASTMAN CHEMICAL COMPANY (US) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041080-A1 CELLULOSE SOLUTIONS COMPRISING TETRAALKYLAMMONIUM ALKYLPHOSPHATE AND PRODUCTS PRODUCED THEREFROM AGPS, THEM6, PCTP LMNA 1766/4885AKT1 2322/4885ESR1 4717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.